The regenerative medicine in oral and maxillofacial surgery: the most important innovations in the clinical application of mesenchymal stem cells
- PMID: 25552921
- PMCID: PMC4278878
- DOI: 10.7150/ijms.10706
The regenerative medicine in oral and maxillofacial surgery: the most important innovations in the clinical application of mesenchymal stem cells
Abstract
Regenerative medicine is an emerging field of biotechnology that combines various aspects of medicine, cell and molecular biology, materials science and bioengineering in order to regenerate, repair or replace tissues. The oral surgery and maxillofacial surgery have a role in the treatment of traumatic or degenerative diseases that lead to a tissue loss: frequently, to rehabilitate these minuses, you should use techniques that have been improved over time. Since 1990, we started with the use of growth factors and platelet concentrates in oral and maxillofacial surgery; in the following period we start to use biomaterials, as well as several type of scaffolds and autologous tissues. The frontier of regenerative medicine nowadays is represented by the mesenchymal stem cells (MSCs): overcoming the ethical problems thanks to the use of mesenchymal stem cells from adult patient, and with the increasingly sophisticated technology to support their manipulation, MSCs are undoubtedly the future of medicine regenerative and they are showing perspectives unimaginable just a few years ago. Most recent studies are aimed to tissues regeneration using MSCs taken from sites that are even more accessible and rich in stem cells: the oral cavity turned out to be an important source of MSCs with the advantage to be easily accessible to the surgeon, thus avoiding to increase the morbidity of the patient. The future is the regeneration of whole organs or biological systems consisting of many different tissues, starting from an initial stem cell line, perhaps using innovative scaffolds together with the nano-engineering of biological tissues.
Keywords: Bone regeneration; Dental Pulp Stem Cells; Mesenchymal Stem Cells; Regenerative medicine; hPCy-MSCs.; human Periapical Cysts Mesenchymal Stem Cells.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
References
-
- Gibble JW, Ness PM. Fibrin glue: the perfect operative sealant? Transfusion. 1990;30:741–7. - PubMed
-
- Saltz R, Sierra D, Feldman D, Saltz MB, Dimick A, Vasconez LO. Experimental and clinical applications of fi brin glue. Plast Reconstr Surg. 1991;88:1005–15. discussion 1016-7. - PubMed
-
- Hotz G. Alveolar ridge augmentation with hydroxylapatite using fibrin sealant for fixation. Part I: An experimental study. Int J Oral Maxillofac Surg. 1991;20:204–7. - PubMed
-
- Hotz G. Alveolar ridge augmentation with hydroxylapatite using fi brin sealant for fi xation. Part II: Clinical application. Int J Oral Maxillofac Surg. 1991;20:208–13. - PubMed
-
- Whitman DH, Berry R, Green D. Platelet gel: an autologous alternative to fibrine glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997;55:1294–9. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
